SEK 37.0
(-1.99%)
Year | Operating Expenses | Operating Expenses Growth |
---|---|---|
2023 | 44.08 Million DKK | 35.79% |
2022 | 32.46 Million DKK | 12.68% |
2021 | 28.8 Million DKK | 30.0% |
2020 | 22.16 Million DKK | 108.2% |
2019 | 10.64 Million DKK | 18309.49% |
2018 | 57.81 Thousand DKK | 0.0% |
Year | Operating Expenses | Operating Expenses Growth |
---|---|---|
2024 Q2 | 8.11 Million DKK | -2.76% |
2024 Q1 | 8.34 Million DKK | -34.6% |
2023 Q3 | 10.86 Million DKK | 25.5% |
2023 FY | 44.36 Million DKK | 36.68% |
2023 Q4 | 12.76 Million DKK | 17.47% |
2023 Q2 | 8.65 Million DKK | -25.67% |
2023 Q1 | 11.64 Million DKK | 4.86% |
2022 FY | 32.46 Million DKK | 12.68% |
2022 Q3 | 8.41 Million DKK | 12.0% |
2022 Q2 | 7.51 Million DKK | 38.4% |
2022 Q1 | 5.42 Million DKK | -43.68% |
2022 Q4 | 11.1 Million DKK | 31.95% |
2021 Q3 | 8.93 Million DKK | 48.13% |
2021 Q2 | 6.03 Million DKK | 43.63% |
2021 Q1 | 4.2 Million DKK | -50.76% |
2021 FY | 28.8 Million DKK | 30.0% |
2021 Q4 | 9.64 Million DKK | 7.85% |
2020 FY | 22.16 Million DKK | 108.2% |
2020 Q4 | 8.53 Million DKK | 173.2% |
2020 Q3 | 3.12 Million DKK | -52.56% |
2020 Q2 | 6.58 Million DKK | 67.81% |
2020 Q1 | 3.92 Million DKK | 3.18% |
2019 Q4 | 3.8 Million DKK | -24.82% |
2019 Q3 | 5.05 Million DKK | 276.26% |
2019 Q2 | 1.34 Million DKK | 204.07% |
2019 Q1 | 442 Thousand DKK | 750.0% |
2019 FY | 10.64 Million DKK | 18309.49% |
2018 Q4 | 52 Thousand DKK | 0.0% |
2018 Q3 | - DKK | 0.0% |
2018 FY | 57.81 Thousand DKK | 0.0% |
2018 Q2 | - DKK | 0.0% |
Name | Operating Expenses | Operating Expenses Difference |
---|---|---|
AddLife AB (publ) | 3.01 Billion SEK | 98.537% |
Biotage AB (publ) | 637 Million SEK | 93.08% |
Bonesupport Holding AB (publ) | 510.93 Million SEK | 91.372% |
Doxa AB (publ) | -259.5 Million SEK | 116.987% |
Elekta AB (publ) | 3.39 Billion SEK | 98.7% |
iZafe Group AB (publ) | 35.92 Million SEK | -22.695% |
Ortivus AB (publ) | 48.45 Million SEK | 9.021% |
Ortivus AB (publ) | 48.45 Million SEK | 9.021% |
Q-linea AB (publ) | -43 Thousand SEK | 102616.279% |
S2Medical AB (publ) | 20.3 Million SEK | -117.143% |
Synsam AB (publ) | 3.76 Billion SEK | 98.828% |